Elypta
Pre-clinicalOur mission is to prevent cancer mortality through early detection by pioneering a metabolism-based liquid biopsy.
Founded
2017
Focus
Diagnostics
About
Our mission is to prevent cancer mortality through early detection by pioneering a metabolism-based liquid biopsy.
Funding History
2Total raised: $23.5M
Series A$21MIndustrifondenJan 15, 2022
Seed$2.5MIndustrifondenJun 15, 2019
Company Info
TypePrivate
Founded2017
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile